Important: New Login Process

We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.

  • If your organization uses Single Sign-On (SSO), you will be redirected to your company's login portal.
  • If you log in with a username and password, you will be prompted to set a new password before accessing your account.

Go to the Login Page to get started.

We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.

BioCentury
ARTICLE | Clinical News

Elobixibat regulatory update

February 8, 2017 10:46 PM UTC

Eisai’s EA Pharma Co. Ltd. subsidiary submitted an NDA in Japan for elobixibat to treat chronic constipation. EA has exclusive rights to elobixibat for gastrointestinal disorders in Japan and other As...

Get Unlimited Access
Continue reading with a free trial.
Or Purchase This Article